A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease is a research paper published in Movement Disorders (2023). On theSindex it has a DataRank of 0. It has been cited 66 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural NIH HHS
Grant: ZIA NS003154
National Institute for Health Research (NIHR)
Grant: CL-2022-04-001
Medical Research Council
Grant: MC_PC_12025
Establishing MRC-NIHR Phenome Centre, a world leading high-throughput metabolic phenotyping centre for humanpopulation disease-risk biomarker discovery.
National Institute for Health Research (NIHR)
Grant: NIHR-INF-0473
National Institute for Health Research (NIHR)
Grant: CL-2019-21-002
National Institute for Health Research (NIHR)
Grant: NIHR-INF-0992
National Institutes of Health
Grant: 1ZIANS003154-09
Genetic characterization of atypical parkinsonism
Jon Moulton Charity Trust
CPT
FWCI
10.69
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals